Professional Marketing briefs
Eli Lilly is trimming its osteoporosis, diabetes and neurosciences sales forces by a total of 191 jobs as part of a restructuring plan announced in September, Indianapolis Business Journal reports. The company intends to lay off 5,500 by 2011 in an effort to soften the blow when Zyprexa, which has $4.7 billion in global sales, goes off patent the same year.
Warner Chilcott completed its $3.1 billion acquisition of P&G's global branded prescription pharmaceuticals unit, securing a 1,200-person sales force and a portfolio worth $2.3 billion in annual revenue. The company, based in Ireland, now markets such former P&G products as blockbuster brand Actonel (risedronate) for osteoporosis and colitis drug Asacol (mesalamine).